Form EFFECT Serina Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 3, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucleus Research Names Zebra Workcloud Task and Workforce Management Solutions Enterprise Leaders
- RevoAI Unveils Aptivio Nexus and Opens UAE Pilot Pathway at ISNR Abu Dhabi 2026
- Configit Named by Deloitte as One of Denmark's Best Managed Companies
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
